|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Evista.(New indication)
November 01, 2007
First-time generic approvals.(FDA Drug Approvals)(Brief article)
November 01, 2007
Reclast Injection.(FDA actions in brief)(Brief article)
November 01, 2007
Norditropin.(FDA actions in brief)(Brief article)
November 01, 2007
Plavix.(FDA actions in brief)(Brief article)
November 01, 2007
Levaquin.(FDA actions in brief)(Brief article)
November 01, 2007
Evithrom.(FDA actions in brief)(Brief article)
November 01, 2007
Azor.(FDA actions in brief)(Brief article)
November 01, 2007
Taxotere.(FDA actions in brief)(Brief article)
November 01, 2007
Focus on 2007: a year of novel pharmacologic agents in review.(Focus o...
November 01, 2007
Rotigotine: The first transdermal nonergot-derived dopamine agonist fo...
November 01, 2007
Use of SSRIs in early pregnancy not associated with increased risk of ...
November 01, 2007
Statins associated with reduction in 10-year risk of cataracts.(News C...
November 01, 2007
GRACE and SCAAR add to the debate about stents.(Meeting Coverage)(Glob...
November 01, 2007
MERLIN: Ranolazine associated with antiarrhythmic effect.(Meeting Cove...
November 01, 2007
Atorvastatin.(Selected literature)
November 01, 2007
Lecozotan SR.(Selected literature)
November 01, 2007
Rosiglitazone XR.(Selected literature)
November 01, 2007
Tarenflurbil.(Selected literature)
November 01, 2007
Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
November 01, 2007
Alzheimer's disease.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE...
November 01, 2007
Unfavorable risk: benefit ratio with antiplatelet plus anticoagulant t...
November 01, 2007
Retaane.(Approvable designations)
November 01, 2007
Lamictal XR.(Approvable designations)
November 01, 2007
Symlin.(Nonapprovable designations)
November 01, 2007
Frova.(Nonapprovable designations)
November 01, 2007
Prexige.(Nonapprovable designations)
November 01, 2007
PI-88 (Progen).(Fast-track designation)
November 01, 2007
Cinryze.(Priority review)
November 01, 2007
Etravirine.(Priority review)
November 01, 2007
IPI-504.(Orphan drug designations)
November 01, 2007
Preos.(Orphan drug designations)
November 01, 2007
Pafuramidine.(Orphan drug designations)
November 01, 2007
Doribax.(New molecular entity )(Doribax Doripenem )
November 01, 2007
Adding prostaglandin blocker to niacin ER reduces flushing without com...
November 01, 2007
|